CellaVision AB Bearer Shs CLVSF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $20.36
- Day Range
- $20.24–20.24
- 52-Week Range
- $16.72–23.75
- Bid/Ask
- $19.71 / $20.75
- Market Cap
- $482.76 Mil
- Volume/Avg
- 500 / 705
Key Statistics
- Price/Earnings (Normalized)
- 39.56
- Price/Sales
- 7.62
- Dividend Yield (Trailing)
- 1.07%
- Dividend Yield (Forward)
- 0.10%
- Total Yield
- 1.07%
Company Profile
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 237
- Website
- https://www.cellavision.com
Comparables
Valuation
|
Metric
|
CLVSF
|
BICO
|
EPEN
|
|---|---|---|---|
Price/Earnings (Normalized) | 39.56 | — | 15.27 |
Price/Book Value | 6.77 | 0.69 | 2.45 |
Price/Sales | 7.62 | 1.55 | 1.27 |
Price/Cash Flow | 27.75 | — | 7.39 |
Price/Earnings
CLVSF
BICO
EPEN
Financial Strength
|
Metric
|
CLVSF
|
BICO
|
EPEN
|
|---|---|---|---|
Quick Ratio | 2.21 | 1.76 | 1.03 |
Current Ratio | 3.22 | 2.41 | 1.78 |
Interest Coverage | 47.13 | −16.51 | 7.02 |
Quick Ratio
CLVSF
BICO
EPEN
Profitability
|
Metric
|
CLVSF
|
BICO
|
EPEN
|
|---|---|---|---|
Return on Assets (Normalized) | 15.38% | −4.22% | 8.07% |
Return on Equity (Normalized) | 20.31% | −6.38% | 19.13% |
Return on Invested Capital (Normalized) | 17.69% | −4.08% | 12.64% |
Return on Assets
CLVSF
BICO
EPEN
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Zbfmkld | Dzzkj | $185.4 Bil | |
SYK
| Stryker Corp | Mxpmpdngq | Tsxfc | $128.2 Bil | |
BSX
| Boston Scientific Corp | Cjwdzgtw | Tnfrw | $107.7 Bil | |
MDT
| Medtronic PLC | Qqxcqrnj | Xytpqr | $105.2 Bil | |
DXCM
| DexCom Inc | Nfqryftqw | Zcs | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Jcdhvkfghm | Zzdbx | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Nylbndvr | Sks | $24.6 Bil | |
ALGN
| Align Technology Inc | Bjkszhfh | Rkqpknc | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Fjdpmjzs | Ckpdddx | $18.7 Bil | |
PODD
| Insulet Corp | Yqtwsnwxjk | Nhzbhh | $11.5 Bil |